Evidence map›Paper›PMID 36424921›Full record

ArticleFrontiers in nutrition2022

Wenfeng Xu, Kaixiang Zou, Ying Zhan, Yunjie Cai, Zhihong Zhang, Xueying Tao, Liang Qiu, Hua Wei

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Food science & nutrition · 2025
    Article
  6. Article
  7. Biodegradation of Cholesterol byMicroorganisms · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Biodegradation of Cholesterol byMicroorganisms · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wenfeng XuState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Kaixiang ZouState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Ying ZhanState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Yunjie CaiState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Zhihong ZhangState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Xueying TaoState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Liang QiuCentre for Translational Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Hua WeiState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, China.
Nanchang University · CNState Key Laboratory of Food Science and Technology · CNJiangxi University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to identify cholesterol-lowering commensal strains from healthy lean individuals and to evaluate the cholesterol-lowering capacity of

Indexed as

cholesterol-loweringEnterococcus faeciumhypercholesterolemiamicrobiotaphysiological performancescreening

Identifiers

PMID36424921
PMCPMC9678928
OpenAlexW4308593989

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.